HLSQ on NYSE

Tessera Defense & Homeland Security Inc.

American prepackaged software services company based in Ness Ziona. Summary from the record

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with another stock.

  • TickerHLSQ on NYSE1
  • IndustryServices-Prepackaged Software1
  • HeadquartersDover, Delaware1
  • Incorporated inDE2
  • Business address850 New Burton Road, Suite 201, Dover, De 199042
  • Filer categoryNon-accelerated filer, Smaller reporting company2
  • Legal formCorporation

See how the biggest companies compare on our leaderboards

Fixed cocktail therapy – in this approach a single product containing a fixed number of selected phages is developed to cover a wide range of bacterial strains, thus allowing treatment of broad patient populations with the same product. Fixed cocktails are developed using our platform, in which high throughput screening, directed evolution, and bioinformatic approaches are leveraged to produce an optimal phage cocktail.3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Operating income456789-$41.5M in 2025+87% since 2019
-$60.0M-$40.0M-$20.0M02019: -$22.2M-$22.2M20192020: -$30.3M-$30.3M2020+36%2021: -$35.5M-$35.5M2021+17%2022: -$27.2M-$27.2M2022−23%2023: -$25.3M-$25.3M2023−7%2024: -$44.5M-$44.5M2024+76%2025: -$41.5M-$41.5M2025−7%
Net income456789-$36.2M in 2025+76% since 2019
-$40.0M-$30.0M-$20.0M-$10.0M02019: -$20.6M-$20.6M20192020: -$30.1M-$30.1M2020+46%2021: -$36.2M-$36.2M2021+20%2022: -$28.3M-$28.3M2022−22%2023: -$26.2M-$26.2M2023−8%2024: -$17.7M-$17.7M2024−32%2025: -$36.2M-$36.2M2025+104%

Every line of the income statement as filed: the last 2 fiscal years, latest first.9

Period ending2025-12-312024-12-31
Research and development (R&D) expenses, net$21.3M$24.7M
General and administrative expenses$9.6M$11.8M
Gain from early lease termination-$2.9M
Goodwill impairment$801.0K
IPR&D impairment$11.8M$3.2M
Other long-lived assets impairment$1.7M$4.0M
Operating loss$41.5M$44.5M
Other expense (income)$93.0K-$2.1M
Interest expenses$20.0K$873.0K
Finance expense , net$724.0K$919.0K
Income from change in fair value of warrants-$6.1M-$26.5M
Loss before tax$36.2M$17.7M
Tax expenses$7.0K$13.0K
Net Loss$36.2M$17.7M
Basic loss per share of Common Stock (in Dollars per share)$22.19$25.37
Diluted loss per share of Common Stock (in Dollars per share)$22.19$58.31
Weighted average number of shares used in computing basic loss per share of Common Stock (in Shares)1.6M shares698.9K shares
Weighted average number of shares used in computing diluted loss per share of Common Stock (in Shares)1.6M shares757.7K shares

Compare Tessera Defense & Homeland Security Inc. with another company

Leadership

Who has led Tessera Defense & Homeland Security Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Jonathan Eitan Solomon2019–now

Chair

  1. Gbolahan Amusa2018

Chief financial officer

  1. George Kaufman2018
  2. Marina Wolfson2022–2023
  3. Avraham Gabay2023
20202025
Board members and other officers (33)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Interim Chief Financial OfficerAvi Gabay named Apr 1, 202448
  • DirectorEddie Williams named Jan 20, 202649
  • DirectorEdward Williams named Apr 1, 202448
  • DirectorJonas Grossman named Oct 25, 2021 to Jan 4, 202250

Former names

  • BiomX Inc.Nov 1, 2019 to Sep 9, 20262
  • Chardan Healthcare Acquisition Corp.May 4, 2018 to Oct 23, 20192

Timeline

  1. Nov 7, 2019New chief executive Jonathan Eitan Solomon becomes CEO13

Filings

374 filings to the SEC since October 2021: 7 annual reports, 15 quarterly reports, 100 major events, 98 insider forms, 53 large holders, 5 private raises, 96 other. The latest 20:

  1. Oct 13, 20268-K CURRENT REPORT EDGAR
  2. Oct 8, 2026DEFA14A DEFINITIVE ADDITIONAL MATERIALS EDGAR
  3. Oct 8, 2026DEFA14A DEFINITIVE ADDITIONAL MATERIALS EDGAR
  4. Oct 7, 20268-K CURRENT REPORT EDGAR
  5. Oct 6, 2026DEF 14A DEFINITIVE PROXY STATEMENT EDGAR
  6. Oct 6, 2026SCHEDULE 13D/A EDGAR
  7. Oct 5, 2026SCHEDULE 13G EDGAR
  8. Oct 5, 20268-K CURRENT REPORT EDGAR
  9. Sep 29, 20268-K CURRENT REPORT EDGAR
  10. Sep 25, 2026PRE 14A PRELIMINARY PROXY STATEMENT EDGAR
  11. Sep 25, 20268-K CURRENT REPORT EDGAR
  12. Sep 22, 20268-K CURRENT REPORT EDGAR
  13. Sep 17, 2026SCHEDULE 13D EDGAR
  14. Sep 15, 20268-K CURRENT REPORT EDGAR
  15. Sep 9, 20268-K CURRENT REPORT EDGAR
  16. Sep 1, 20268-K CURRENT REPORT EDGAR
  17. Sep 1, 20268-K/A AMENDMENT NO. 1 TO FORM 8-K EDGAR
  18. Aug 28, 20268-K CURRENT REPORT EDGAR
  19. Aug 25, 20268-K CURRENT REPORT EDGAR
  20. Aug 20, 2026SCHEDULE 13G/A EDGAR

The 374 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

72 open-market trades by officers, directors and large owners since October 2021: 4 buys and 68 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Mar 17, 2026Yeganeh ReuvenDirectorSale530,000$5.00$2.6MForm 4
Mar 16, 2026Yeganeh ReuvenDirectorSale450,000$5.00$2.2MForm 4
Mar 13, 2026Yeganeh ReuvenDirectorSale370,000$5.00$1.9MForm 4
Mar 12, 2026Yeganeh ReuvenDirectorSale300,000$5.00$1.5MForm 4
May 15, 2024GORDON CARL L10% ownerSale24,344$0.38$9.3KForm 4
Nov 29, 2023Oron AssafChief Business OfficerSale10,914$0.37$4.1KForm 4
May 22, 2023Oron AssafChief Business OfficerBuy3,192$0.27$862Form 4
May 19, 2023Oron AssafChief Business OfficerBuy6,521$0.28$1.8KForm 4
May 18, 2023Oron AssafChief Business OfficerBuy1,201$0.27$324Form 4
Feb 27, 2023OrbiMed Israel GP Ltd.10% ownerBuy348,000$0.25$87.0KForm 4
Nov 4, 2022Ugwumba ChidozieSale1,501$0.38$570Form 4
Nov 3, 2022Ugwumba ChidozieSale2,000$0.37$740Form 4
Nov 2, 2022Ugwumba ChidozieSale2,416$0.36$870Form 4
Nov 1, 2022Ugwumba ChidozieSale1,300$0.36$468Form 4
Oct 31, 2022Ugwumba ChidozieSale3,300$0.37$1.2KForm 4
Oct 28, 2022Ugwumba ChidozieSale1,526$0.36$549Form 4
Oct 27, 2022Ugwumba ChidozieSale1,505$0.36$542Form 4
Oct 26, 2022Ugwumba ChidozieSale12,500$0.35$4.4KForm 4
Oct 25, 2022Ugwumba ChidozieSale3,072$0.37$1.1KForm 4
Oct 24, 2022Ugwumba ChidozieSale5,900$0.35$2.1KForm 4

All 72 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Jan 13, 2026Raised $3.3 million in a private offering of equity Form D: 1 investor so far Form D
  2. Mar 15, 2024Raised $61.5 million in a private offering of equity Form D: 34 investors so far Form D
  3. Feb 27, 2023Raised $1.5 million in a private offering of equity Form D: $7.5 million offered in all Form D
  4. Dec 21, 2021Raised $3 million in a private offering of equity Form D: $5 million offered in all Form D
  5. Oct 14, 2021Raised $3 million in a private offering of equity Form D: 1 investor so far Form D

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67